We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN.B icon
2626
Lennar Class B
LEN.B
$19.9B
$263K ﹤0.01%
6,281
-1,971
-24% -$79.8K
BLMT
2627
DELISTED
BSB Bancorp, Inc.
BLMT
$262K ﹤0.01%
+8,964
New +$262K
HONE
2628
DELISTED
HarborOne Bancorp
HONE
$261K ﹤0.01%
23,471
+637
+3% +$7.14K
MGNI icon
2629
Magnite
MGNI
$2.83B
$259K ﹤0.01%
50,449
+7,502
+17% +$41.2K
HIFS icon
2630
Hingham Institution for Saving
HIFS
$624M
$258K ﹤0.01%
+1,420
New +$251K
ACTG icon
2631
Acacia Research
ACTG
$437M
$257K ﹤0.01%
62,741
-1,151
-2% -$5.36K
ZAGG
2632
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$257K ﹤0.01%
29,732
-2,105
-7% -$16.8K
BHVN
2633
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$257K ﹤0.01%
+10,272
New +$237K
SMMF
2634
DELISTED
Summit Financial Group, Inc.
SMMF
$255K ﹤0.01%
+11,597
New +$254K
SPA
2635
DELISTED
Sparton
SPA
$255K ﹤0.01%
11,596
+150
+1% +$2.96K
FBK icon
2636
FB Financial Corp
FBK
$2.98B
$254K ﹤0.01%
+7,023
New +$252K
MCRB icon
2637
Seres Therapeutics
MCRB
$45M
$254K ﹤0.01%
1,124
+145
+15% +$29.8K
OCUL icon
2638
Ocular Therapeutix
OCUL
$1.83B
$254K ﹤0.01%
27,386
+4,958
+22% +$48K
ODC icon
2639
Oil-Dri
ODC
$1.43B
$254K ﹤0.01%
12,074
-1,110
-8% -$21.3K
AXTI icon
2640
AXT Inc
AXTI
$2.42B
$253K ﹤0.01%
+39,804
New +$260K
SFST icon
2641
Southern First Bancshares
SFST
$581M
$253K ﹤0.01%
+6,816
New +$234K
KEG
2642
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$253K ﹤0.01%
+13,173
New +$273K
STML
2643
DELISTED
Stemline Therapeutics, Inc.
STML
$252K ﹤0.01%
27,358
+4,280
+19% +$35.7K
BOLD
2644
DELISTED
Audentes Therapeutics, Inc
BOLD
$252K ﹤0.01%
+13,181
New +$211K
OLBK
2645
DELISTED
Old Line Bancshares, Inc.
OLBK
$252K ﹤0.01%
8,939
+415
+5% +$11.6K
ZOES
2646
DELISTED
Zoe's Kitchen, Inc.
ZOES
$252K ﹤0.01%
21,143
+155
+0.7% +$2.48K
RPT
2647
Rithm Property Trust
RPT
$94.4M
$251K ﹤0.01%
3,093
+416
+16% +$33.1K
ASC icon
2648
Ardmore Shipping
ASC
$683M
$250K ﹤0.01%
30,635
-465
-1% -$3.59K
CVLY
2649
DELISTED
Codorus Valley Bancorp Inc
CVLY
$249K ﹤0.01%
10,144
+509
+5% +$11.9K
SFS
2650
DELISTED
Smart & Final Stores, Inc.
SFS
$249K ﹤0.01%
27,359
-156
-0.6% -$1.86K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.